It has been proposed that elevated serum FGF21 levels in individuals with obesity and rodents result from FGF21 resistance in adipose tissues due to reduced expression of its receptor complex (Fisher et al, 2010; Geng et al, 2019; Li et al, 2018). The gene discussed is FGF21; the disease is obesity disorder.